Position in ATYR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$131,424
-$423,236 QoQ
Shares Held
220,141
-69.0% QoQ
Ownership
0.224%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 90 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ATYR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,568,275 across 424 Biotechnology names. ATYR ranks #343 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in ATYR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $131,424 | 220,141 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $554,660 | 711,105 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $549,810 | 702,186 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $486,041 | 674,122 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $3,452,343 | 680,936 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $563,583 | 186,617 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $661,102 | 182,625 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $230,232 | 130,814 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $184,791 | 118,456 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $193,373 | 99,166 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $141,143 | 100,102 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $124,060 | 78,519 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $250,406 | 115,929 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $148,270 | 70,605 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $100,457 | 45,871 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $137,613 | 45,871 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $129,814 | 45,871 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $237,572 | 44,406 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $331,712 | 44,406 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $224,030 | 24,673 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $127,392 | 26,105 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $98,046 | 22,033 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $85,150 | 21,946 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $66,725 | 20,658 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $91,721 | 20,658 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||